iShares LifePath Target Date 2030 ETF (NYSEARCA:ITDB) Stock Jumps 0.1% – Here’s What Happened

iShares LifePath Target Date 2030 ETF (NYSEARCA:ITDB – Get Free Report) traded up 0.1% during mid-day trading on Tuesday. The stock traded as high as $34.95 and last traded at $34.93. 13,682 shares changed hands during mid-day trading, a decline of 27% from the average daily volume of 18,788 shares. The stock had previously closed at $34.90.

iShares LifePath Target Date 2030 ETF Stock Performance

The stock has a market capitalization of $81.67 million, a PE ratio of 20.07 and a beta of 0.58. The stock’s 50 day moving average is $35.14 and its two-hundred day moving average is $34.72.

Hedge Funds Weigh In On iShares LifePath Target Date 2030 ETF

An institutional investor recently raised its position in iShares LifePath Target Date 2030 ETF stock. Capital Advisors Ltd. LLC grew its position in iShares LifePath Target Date 2030 ETF (NYSEARCA:ITDB – Free Report) by 21.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,430 shares of the company’s stock after acquiring an additional 613 shares during the quarter. Capital Advisors Ltd. LLC owned about 0.19% of iShares LifePath Target Date 2030 ETF worth $112,000 as of its most recent SEC filing.

About iShares LifePath Target Date 2030 ETF

(Get Free Report)

The iShares LifePath Target Date 2030 ETF (ITDB) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2030 ITDB was launched on Oct 17, 2023 and is issued by BlackRock.

Featured Stories

Receive News & Ratings for iShares LifePath Target Date 2030 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares LifePath Target Date 2030 ETF and related companies with MarketBeat.com's FREE daily email newsletter.